IQE PLC
29 September 2002
30th SEPTEMBER 2002
IQE and Rockwell settle Lawsuit ; IQE Trading Update
IQE plc and Rockwell Automation Inc, have announced today that they have settled
their disputes relating to MOCVD process patents held by Rockwell Automation,
which were part of a Licensing Agreement between the Companies, during the
period October 1991 to January 2000.
The settlement agreement includes a cash payment by IQE and the issue of 300,000
shares of IQE ordinary shares of 1p to Rockwell Automation.
In return Rockwell Automation has agreed to release and discharge IQE and all of
its customers, past, present and future, from any obligations under any Rockwell
MOCVD process patents in relation to wafers purchased from IQE.
Consequently, application has today been made to the UK Listing Authority and
the London Stock Exchange for 300,000 ordinary shares of 1p each in the Company
('Ordinary Shares') to be admitted to the Official list. The Ordinary Shares are
being issued to Rockwell Automation Inc as part consideration of the Settlement
Agreement. Admission is expected to become effective 1st October 2002.
The cash element of the settlement falls within the £750K estimated by IQE in
its first half interim results statement as the legal expenses which would have
been necessary to prosecute trial of the matter, due to have gone to Court in
January 2003. The IQE Board has considered that it is more appropriate to settle
the case now with certainty and concentrate all corporate efforts on increasing
current business opportunities.
The cost of settlement will be charged to the Profit and Loss Account in Q3,
2002.
Current trading remains difficult, with no appreciable change in the marketplace
dynamics from that given by the Group in its interim statement of six weeks ago.
The wireless portion of the business continues to grow and there is increasing
interest in the Group's strained Silicon product for next generation
microprocessors and other electronic applications. The optoelectronic
marketplace for communication devices however, remains very depressed, although
the Group is making progress on its visible laser (DVD) product range and
developing its LED strategy. The substrate business has remained relatively flat
during Q3.
Due to the continued decline in the opto-electronics industry for communications
and the seasonal impact of shutdowns of many companies during Q3, particularly
in Europe, Group sales for Q3 are expected to be in the range of £5.4 - £5.6
million.
The actions arising from the strategic review announced earlier have been fully
implemented and further cost cutting initiatives are continuing to be introduced
across the Group. The effect of these changes on cash outflows in Q3 (currently
expected to be approximately £4 million) is likely to be minimal. Their overall
impact on cashflow will only become evident in Q4 and beyond. A full Q3
statement is due on 20th November 2002.
For further information please contact :
Nelson, IQE plc 02920 839405
Tim Hawkes, IQE plc 02920 839419
Chris Meadows, IQE plc 02920 839472
Matthew Wood, Evolution Beeson Gregory 0207 488 4040
Nicola Cronk/Fergus Mellon, Buchanan Communications 0207 466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.